Skip to content

Preventing of auricular acupuncture for migriane: a randomized controlled trial

Auricular acupuncture for treatment of migraine: a clinical observation research

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010760
Enrollment
Unknown
Registered
2017-03-02
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

A:Auricular needling at TF4, AH6, CO15 of CO10, CO12, CO15 alternatively twice a week
B:Sham-auricular needling at TF4, AH6, CO15 of CO10, CO12, CO15 alternatively twice a week
C:Auricular needling at A-shi points twice a week
D:Sham-auricular needling at A-shi points twice a week

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Signed informed consent migraineur, aged 18 to 65 years old, without aura or any auricular acupuncture experience who have gotten mild cephalagia, scored 4-7 by VAS scale, during 10 years or above.

Exclusion criteria

Exclusion criteria: 1) Cephalagia caused by organic disorders (eg,subarachnoid hemorrhage, cerebral hemorrhage, cerebral infarction, cerebral embolism, vascular malformation, arthritis, high blood pressure, arteriosclerosis, etc.); 2) the presence of serious organic disorders,bleeding,cognitive dysfunction, aphasia, mental disorder, or fail to cooperate with treatment or follow-ups; 3) with pregnancy or lactation; 4) allergic to metal; 5) refuse auricular needling; 6) participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Comparing intensity reduction among 4 groups from 9th to 12th week;Comparing frequency reduction among 4 groups from 9th to 12th week;

Secondary

MeasureTime frame
Comparing intensity reduction among 4 groups from 13th to 20th week;Comparing frequency reduction among 4 groups from 13th to 20th week;Comparing life quality among four groups at baseline and 9th to 20th week;

Countries

China

Contacts

Public ContactMengyue Liu

West China Hospital of Sichuan University

729439676@qq.com+86 13402827927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026